AI-based Clinical Trials Solution Provider Market Share, Forecast

1
AI-based Clinical Trials Solution Provider Market
Size Worth USD 7.75 Billion in 2030
www.emergenresearch.com
Increasing adoption of AI-enabled digital health
technology and increasing focus to reduce
clinical trial costs and duration are some key
factors driving market revenue growth
2
Our Model
Market Analysis
Financial Analysis
Distribution Channel Analysis
Brand Analysis
Custom Market Intelligence
Competitor Analysis
Product Analysis
Custom Research
www.emergenresearch.com
Demand Analysis
Risk Analysis
3
Business Plan Parameters
End Use Analysis
Demand Availability Analytics
Market Entry Strategy
Restructuring Revival
New Product Strategy
Product Planning / Strategy
SWOT Analysis
Marketing / Distribution Channel Feasibility
www.emergenresearch.com
Customer Identification Survey
Competitive Landscape / MA Feasibility
www.emergenresearch.com
4
Industries We Cater to
www.emergenresearch.com
5
5
Market Summary
The global AI-based clinical trials solution
provider market size reached USD 1.30 Billion in
2021 and is expected to register a revenue CAGR
of 22 during the forecast period, according to
latest analysis by Emergen Research. Increasing
adoption of Artificial Intelligence (AI)-enabled
digital technology is a key factor driving global
AI-based clinical trials solution provider market
revenue growth. Increasing use of AI-enabled
digital health technologies coupled with patient
support platforms is expected to improve patient
engagement and retention throughout study
duration as well as after study termination,
which is expected to propel revenue growth of the
global AI-based clinical trial solution provider
market. AI-enabled technologies are enabling data
integration and interpretation along with
evolutionary modelling and pattern recognition
for gathering, normalizing, analyzing, and
harnessing the growing volumes of data that fuel
modern therapy development.
www.emergenresearch.com
6
Market Summary
Some Key Highlights From the Report Phase-II
segment is expected to account for largest
revenue share over the forecast period,
attributable to increasing number of second phase
clinical trials active in the field of oncology
and increasing focus on phase-II trail for
developing effective treatment approach for
specific types of diseases such as acute
leukemia, glioblastoma, and Alzheimers
disease. Cancer segment is expected to account
largest revenue share over the forecast period
due to rising focus on integrating AI in cancer
care to improve speed and accuracy of cancer
diagnosis, to aid in clinical decision-making,
and lead to improved healthcare outcomes, coupled
with increasing investment in AI-enabled clinical
trials to develop novel therapeutic drugs for
cancer treatment. Contract Research
Organizations (CROs) segment is expected to
register a significantly robust CAGR in terms of
revenue over the forecast period owing to rising
implementation of AI-based solutions to improve
clinical trial design, increasing number of
research studies conducted to develop
therapeutics for cardiovascular diseases, cancer,
metabolic disorders, Central Nervous System
Disorders (CNS), and increasing number of
partnerships with biopharmaceutical companies in
niche drug discovery.
www.emergenresearch.com
7
Market Summary
Some Key Highlights From the Report Some key
players in the market include AiCure, LLC,
Unlearn.AI, Inc., BioAge Labs Inc., Antidote
Technologies, Inc., Saama Technologies Inc.,
International Machine Business Corporation (IBM),
Concentro Health AI, Deep 6 AI Inc., PathAI Inc.,
and Owkin Inc. Request Free Sample Copy_at_
https//www.emergenresearch.com/request-sample/774

www.emergenresearch.com
8
Market Summary
Emergen Research has segmented the global
AI-based clinical trials solution provider market
on the basis of clinical trial phase, therapeutic
application, end-use, and region Clinical Trial
Phase Outlook (Revenue, USD Billion
20192030) Phase-I Phase-II Phase-III Therapeutic
Application Outlook (Revenue, USD Billion
20192030) Cancer Cardiovascular
Disease Neurological Disease Metabolic
Disease Infectious Disease Others End-use Outlook
(Revenue, USD Billion 20192030) Pharmaceuticals
Academia Contract Research Organizations
(CROs) Read more _at_ https//www.emergenresearch.co
m/industry-report/ai-based-clinical-trials-solutio
n-provider-market
9
Parameter Details
Market Size Estimation Period 2022-2030
Base Year Considered 2021
Historical Data 2019-2020
Forecast Period 2022-2030
Quantitative Units Revenue in USD million CAGR from 2020 to 2028
Segments Covered Types, Application, End-Users, Regions more.
Countries Included The U.S., Germany, U.K., Italy, China, India, Japan, Brazil
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Regions Scope North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Customization Scope 10 hours of free customization expert consultation
Pricing and Purchase Options Explore Different Purchase Options Request for Discount to Avail New Year Discount
MARKET SEGMENTATION
www.emergenresearch.com
10
Regional Share Dynamics
www.emergenresearch.com
11
LATEST PUBLICATIONS
Latest published reports from the Healthcare
Sector by Emergen Research https//www.emergenre
search.com/industry-report/spherical-graphite-mark
et https//www.emergenresearch.com/industry-report
/fermented-food-and-ingredients-market https//www
.emergenresearch.com/industry-report/electric-comm
ercial-vehicle-market https//www.emergenresearch.
com/industry-report/multi-rotor-drone-market https
//www.emergenresearch.com/industry-report/plastic
-waste-management-market https//www.emergenresear
ch.com/industry-report/pvdf-membrane-market
www.emergenresearch.com
12
About Us
At Emergen Research, we believe in advancing with
technology. We are a growing market research and
strategy consulting company with an exhaustive
knowledge base of cutting-edge and potentially
market-disrupting technologies that are predicted
to become more prevalent in the coming
decade. Our expertise umbrellas the
technological environment of all major
industries, and our services help you map your
actions to ensure optimal yield. Our analysts
utilize their market proficiency to offer
actionable insights that help our clients
implement profitable strategies and optimize
their return on investment. Our services are
wide-ranging, right from technological
environment analysis to technological profiling
that highlights the existing opportunities in the
market you can capitalize on to stay ahead of
your competitors.
www.emergenresearch.com
13
Lets Talk Contact Information
Reach out to us and our Research Executives will
ensure you get the report that meets all your
requirements and address all your concerns.
14671 110 Avenue, Surrey, British Columbia, V3R2A9
www.emergenresearch.com
www.emergenresearch.com
sales_at_emergenresearch.com
1 [phone]